HIGHLIGHTS
- who: SQSTM et al. from the Division of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang, China have published the Article: LncRNA MDRL Mitigates Atherosclerosis through miR-361/ SQSTM1/NLRP3 Signaling, in the Journal: Mediators of Inflammation of 21/09/2022
- what: The authors sought to investigate the role of MDRL in the development of atherosclerosis. In the present study, the authors identified a novel mechanism through which lncRNA MDRL represses VSMC apoptosis and retards the progression of atherosclerosis. In contrast with these phenomena, the study showed that effective delivery of miR-361 partly . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.